- Home
- CRVS vs WSBF Comparison
CRVS vs WSBF Comparison
Compare CRVS & WSBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- WSBF
- Stock Information
- Founded
- CRVS 2014
- WSBF 1921
- Country
- CRVS United States
- WSBF United States
- Employees
- CRVS N/A
- WSBF N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- WSBF Savings Institutions
- Sector
- CRVS Health Care
- WSBF Finance
- Exchange
- CRVS Nasdaq
- WSBF Nasdaq
- Market Cap
- CRVS 257.0M
- WSBF 269.9M
- IPO Year
- CRVS 2016
- WSBF N/A
- Fundamental
- Price
- CRVS $2.99
- WSBF $12.57
- Analyst Decision
- CRVS Strong Buy
- WSBF
- Analyst Count
- CRVS 5
- WSBF 0
- Target Price
- CRVS $12.63
- WSBF N/A
- AVG Volume (30 Days)
- CRVS 715.8K
- WSBF 36.5K
- Earning Date
- CRVS 05-05-2025
- WSBF 04-29-2025
- Dividend Yield
- CRVS N/A
- WSBF 4.74%
- EPS Growth
- CRVS N/A
- WSBF 118.94
- EPS
- CRVS N/A
- WSBF 1.01
- Revenue
- CRVS N/A
- WSBF $135,638,000.00
- Revenue This Year
- CRVS N/A
- WSBF N/A
- Revenue Next Year
- CRVS N/A
- WSBF N/A
- P/E Ratio
- CRVS N/A
- WSBF $13.29
- Revenue Growth
- CRVS N/A
- WSBF 3.74
- 52 Week Low
- CRVS $1.30
- WSBF $10.60
- 52 Week High
- CRVS $10.00
- WSBF $16.86
- Technical
- Relative Strength Index (RSI)
- CRVS 26.38
- WSBF 28.66
- Support Level
- CRVS $3.06
- WSBF $13.20
- Resistance Level
- CRVS $3.31
- WSBF $13.87
- Average True Range (ATR)
- CRVS 0.36
- WSBF 0.37
- MACD
- CRVS -0.10
- WSBF -0.07
- Stochastic Oscillator
- CRVS 1.11
- WSBF 4.64
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, It operates in two segments: Community Banking and Mortgage Banking. The community banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the community banking segment.